Related Experiment Videos

Sotalol-induced bradycardia reversed by glucagon

C M Fernandes¹, M R Daya

¹Department of Emergency Medicine, St Paul's Hospital, Vancouver.

Canadian Family Physician Medecin De Famille Canadien

|April 1, 1995

Abstract:

Glucagon is considered the drug of choice for treating bradycardia and hypotension encountered during beta-blocker poisoning. Its potential usefulness in reversing adverse effects encountered during therapeutic dosing with beta-blockers has not been well characterized. We present a case of sotalol-induced bradycardia reversed by glucagon.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Functional characterization of the Aspergillus nidulans glucosylceramide pathway reveals that LCB Δ8-desaturation and C9-methylation are relevant to filamentous growth, lipid raft localization and Psd1 defensin activity.

Molecular microbiology·2016

Combination of heterogeneous EEG feature extraction methods and stacked sequential learning for sleep stage classification.

International journal of neural systems·2013

Medicolegal significance of asymmetrical hearing loss in cases of industrial noise exposure.

The Journal of laryngology and otology·2010

The snake venom metalloproteinase BaP1 induces joint hypernociception through TNF-alpha and PGE2-dependent mechanisms.

British journal of pharmacology·2007

Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom.

Muscle & nerve·2003

Molecular modelling and 1H-NMR: ultimate tools for the investigation of tolbutamide: beta-cyclodextrin and tolbutamide: hydroxypropyl-beta-cyclodextrin complexes.

Chemical & pharmaceutical bulletin·2001

See all related articles